← All trials
NCT04725747
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 25, 2021
- Primary completion
- May 30, 2021
- Completion date
- Jun 30, 2021
- First posted
- Jan 27, 2021
- Last posted
- Jan 27, 2021
- Enrollment
- 50
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Vance Thompson VisionLead sponsor
- Vance Thompson VisionReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.